"Older patients often tolerate medications poorly and younger patients may feel lethargic and tired with beta blockers and calcium channel blockers. These patients would be appropriate candidates for ...

A 42-year-old woman with obstructive hypertrophic cardiomyopathy (HCM) was referred for alcohol septal ablation (ASA). She had been diagnosed with HCM 20 years earlier following presentation with ...

The occurrence of high-grade conduction disturbances after alcohol septal ablation (ASA) did not translate into worse long-term survival for people with obstructive hypertrophic cardiomyopathy (HCM), ...

Over the long term, patients with obstructive hypertrophic cardiomyopathy (HCM) who require a permanent pacemaker after alcohol septal ablation (ASA) fare just as well as those who don’t, a ...

Hypertrophic cardiomyopathy is an inherited condition that affects up to 750,000 people in the United States. It often involves left ventricular outflow tract obstruction. Septal reduction therapies ...

Please provide your email address to receive an email when new articles are posted on . Alcohol septal ablation for obstructive hypertrophic cardiomyopathy was associated with greater rate of 10-year ...

Please provide your email address to receive an email when new articles are posted on . In patients with obstructive hypertrophic cardiomyopathy, septal reduction therapy was associated with reduced ...

The Hospital de Santa Marta, Lisbon, Portugal, part of Portugal’s National Health Service, has introduced radiofrequency septal ablation, a procedure developed within Brazil’s public health system at ...

Findings from a Cleveland Clinic-led clinical trial showed that the use of an experimental drug in severely symptomatic, hypertrophic cardiomyopathy patients significantly reduced the need for ...

Trichy: A 21-year-old pregnant woman who had thickened heart (HCM) with severe obstruction to blood flow underwent Alcohol Septal Ablation at Kauvery Hospital Heartcity in Trichy. A hospital release ...

HANGZHOU, China, March 4, 2023 /PRNewswire/ -- On March 3, Venus Medtech (Hangzhou) Inc. (Venus Medtech, 2500.HK), trailblazer in structural heart therapies worldwide, announced that the Liwen RF™ ...